Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy

Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy

  • CN 102,625,847 A
  • Filed: 06/15/2010
  • Published: 08/01/2012
  • Est. Priority Date: 06/15/2009
  • Status: Active Application
First Claim
Patent Images

1. the method for triglyceride level in the reduction object;

  • Said object in stable Statins therapy, have about 200mg/dl to the baseline of about 500mg/dl empty stomach triglyceride level;

    Said method comprises giving every day with said object and contains the pharmaceutical composition of 1g to the ultrapure EPA of about 4g of having an appointment;

    Wherein, every day is given the time period in 12 weeks together to after arriving said object with said compsn in (1);

    Be compared to maintain and stablize Statins therapy, the ultrapure EPA not together placebo object of the time period in totally 12 weeks;

    Said object shows the empty stomach triglyceride level of at least 5% reduction, and (2) said object does not show that basically serum LDL-C increases and (3) said placebo object also has the baseline empty stomach triglyceride level of about 200mg/dl to about 500mg/dl.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×